FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.
Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.
Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care









